Prevention and early detection of lung cancer-clinical aspects

Lung Cancer

Volumn 17, Issue 1, 1997, Pages 163-174

  Hirsch, Fred R ^a   Brambilla, Elisabeth ^b   Gray, Nigel ^c   Gritz, Ellen ^d   Kelloff, Gary J ^e   Linnoila, R Ilona ^e   Pastorino, Ugo ^f   Mulshine, James L ^e  

^a FINSEN LABORATORY   (Denmark)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF TEXAS   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA CAROTENE; ANTIOXIDANT; BETA CAROTENE; BIOLOGICAL MARKER; CAROTENOID; CYANOCOBALAMIN; FENRETINIDE; FOLIC ACID; ISOTRETINOIN; LIPOSOME; LYCOPENE; NICOTINE; NICOTINE GUM; OLTIPRAZ; PHENETHYL ISOTHIOCYANATE; POLYPHENOL; RETINOID; RETINOL PALMITATE; SELENIUM;

AEROSOL; CANCER DIAGNOSIS; CANCER PREVENTION; CARCINOMA IN SITU; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EARLY DIAGNOSIS; HEALTH CARE POLICY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG CANCER; MEDICAL RESEARCH; NIGHT BLINDNESS; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING CESSATION; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

HUMANS; LUNG NEOPLASMS; SMOKING;

EID: 0030956343     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00033-0     Document Type: Conference Paper

References (26)

1. Battey JF, Brown PH, Gritz ER, et al. Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer Workshop, Lung Cancer 1995;12:91-103.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics 1997. Cancer J Clin 1997;47:5-26.
3. Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 1992;339:1268.
4. Samet JM, Nero AV. Indoor radon and lung cancer. N Engl J Med 1989;320:591-4.
5. Janerich DT, Thompson WD, Varela LR, et al. Lung cancer and exposure to tobacco smoke in the household. N Engl J Med 1990;323:632-6.
6. Strauss G, De Camp M, Dibbicaro E, Richards W, et al. Lung cancer diagnosis is being made with increasing frequency in former cigarette smokers. Proc ASCO 1995;14:362.
7. Boyle P, Maisonneuve P. Lung cancer and tobacco smoking. Lung Cancer 1995;12:167-81.
8. International Association for the Study of Lung Cancer (IASLC). Tobacco policy recommendations of the International Association of Lung Cancera ten point program. Lung Cancer 1994;11:405-407.
9. Smart CR. Annual screening using chest X-ray examination for the diagnosis of lung cancer. Cancer 1993;72:2295-8.
10. Saccomanno G, Archer VE, Auerbach O, et al. Cancer of the lung; the cytology of sputum prior to the development of carcinoma. Acta Cytol 1965;9:413-23.
11. Lilienfeld A, Archer PG, Burnett CH, et al. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: A cooperative pilot study of the American Cancer Study and the Veterans Administration. Cancer Res 1966;26:2083.
12. Qin D-X, Li J-Y, Sun L-Q, et al. Sputum occult blood screening for lung cancer. Cancer 1991;67:1960-3.
13. Bunn PA. Tumor markers. In: Cecil's Textbook of Medicine, 19th edition. W.B. Saunders Comp. Philadelphia. 1992;1034-1037.
14. Zhou J, Mulshine JL, Unsworth E, et al. Purification and Characterization of a Protein Which Permits Early Detection of Lung Cancer: Identification of Heterogeneous Nuclear Ribonucleoprotein-A2/B1 as the Antigen for Monoclonal Antibody, 703D4. J Biol Chem 1996;271:10760-6.
15. Yakubovskaya MS, Spiegelman V, Luo FC, et al. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int J Cancer 1995;63:810.
16. Lippman S, Benner S, Hong WK. Cancer Chemoprevention. J Clin Oncol 1994;12:851.
17. Kelloff GJ, Boone CW. Cancer Chemopreventive Agents: Drug Development Status and Future Prospects. J Cell Biochem 1995;22(Suppl):1-259.
18. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors in squamous cell carcinoma of the head and neck with 13-cis-retinoic acid. N Engl J Med 1990;323:795.
19. Costa A, Formelli F, Chiesa F, et al. Prospects of chemoprevention of human cancers with the synthetic retinoid, fenretinide. Cancer Res 1994;54:2032S-7S.
20. Oridate N, Lotan D, Xu X-C, Hong WK, Lotan R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in head and neck squamous cell carcinoma cell lines. Clin Cancer Res 1996;2:855-63.
21. DeVries N, Van Zandwijk N, Pastorino U. The EUROACAN Study. Br J Cancer 1991;64:985-9.
22. Szabo E, Mulshine JL. Lung cancer prevention: historical and future perspectives. In: Aisner J, Arrigada R, Green MR, Martini N, Perry MC, editors. Comprehensive Textbook of Thoracic Oncology, Baltimore: Williams and Wilkins, 1996:90.
23. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer 1953;6:963-8.
24. Auerbach O, Gere JB, Forman JB, et al. Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med 1957;256:97.
25. Mulshine JL, Zhou J, Treston AM, et al. New approaches to the integrated management of early lung cancer. Hem Oncol Clinic N Am, in press.
26. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993;329:1318.